Alejandro Bernal

Alejandro Bernal, PhD, is a seasoned professional in the field of oncology, currently serving as the Group Director and Integrated Evidence Team Lead for the Prostate Portfolio at The Janssen Pharmaceutical Companies of Johnson & Johnson. With a PhD in Immunology from Cornell University, Alejandro has held various influential positions, including Integrated Evidence Team Lead for Solid Tumors and Global Director of Scientific Communications at GSK. Over the years, Alejandro has contributed to the medical affairs landscape through roles at Bristol-Myers Squibb and multiple leadership positions within ApotheCom. Alejandro's extensive background combines expertise in scientific strategy, medical education, and innovative drug discovery methodologies.